中医医学论文范文(4)
[4] Delano BG.Improvements in quality of life following treatment with rhEPO in anemic hemodialysis patients[J].Am J Kidney Dis，1989，14(2):14-18.
[5] 王海燕.肾脏病学[M].北京：人民卫生出版社，1998：1396-1399.
[6] Metzen E，Ratcliffe PJ.HIF hydroxylation and cellular oxygen sensing[J]. Biol Chem，2004，385(3-4):223-230.
[7] Candian erythropoietin study group.Association between recombinant human erythropoietin and quality of life and execise capacity of patients receiving haemodialysis[J].BMJ，1990，300(6724)：573-578.
[8] 程玮，杜晓莉，江滔，等.多剂量皮下注射重组人促红细胞生成素在健康人体的药代动力学[J].中国临床药理学杂志，2005，21(2)：132-135.
[9] Frifelt JJ，Tvedegaard E，Bruun K，et a1.Efficacy of recombinant human erythropoietin administered subcutaneously to CAPD patients once weekly[J].Perit Dial Int，1996，16(6)：594-598.
[10] Kaufman JS，Reda DJ，Fye CL,et al.Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis.Department of Veterans Affairs Cooperative Study Group on Erythlipoietin in Hemodialysis Patients[J].N Engl J Med, 1998, 339(9)：578-583.
